KERNX Health review
The consultation is priced as three named tiers and is charged only when treatment is approved.
The verdict
KERNX Health advertises founding rates of $129 and $199 a month. The standard rates behind them are $249 and $299. A provider consultation fee of $25 to $60 is charged separately, and only on approval.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- States
- 50
- From
- $129/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
KERNX Health sells compounded semaglutide and compounded tirzepatide. Both are weekly injections. The rates read $129 and $199 a month on August 7, 2026. Both are described as founding rates. The standard rates are $249 and $299. Coverage is published as fifty states.
Who writes the prescription, and what do they see?
The consultation fee is billed apart from the medication rate. It is charged only when treatment is approved. Three tiers are published. A message-based review is $25. A standard live visit is $35. A complex live visit is $60. An applicant who is declined pays none of them.
Care is arranged remotely. Two charges apply rather than one. The medication rate is monthly. The consultation fee is charged at approval. The founding rate names a pricing cohort, not a recurring membership charge. Nothing else was recorded beside either figure on August 7, 2026.
What happens when the dose goes up?
Both rates are stated as flat at every dose. An escalation does not move the medication charge. The first sixteen weeks are an escalation for most patients. Whether a dose change triggers a further visit fee is not published. A second visit inside that window is therefore possible.
What the price includes
$129 is a founding rate. The standard rate is $249. The gap is $120 a month. The founding rate ends when the cohort closes. No closing date is published. Add $25 to $60 once, at approval. Tirzepatide follows the same shape at $199 and $299.
What it claims, and what it cites
Both products are compounded. A pharmacy prepares them. No regulator reviews the finished vial. A compounded preparation is not FDA-approved. The published trial results used the approved products at label doses. A compounded vial was not what those trials measured.
Where it holds up, and where it does not
- Strength: Consultation fee published as three tiers
- Strength: Fee charged only on approval
- Strength: Rate flat at every dose
- Limitation: Founding rate has no stated end date
- Limitation: Standard rate is $120 higher
- Limitation: Consultation billed apart from the rate
What the evidence says about this kind of treatment
The assessment above is about KERNX Health. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants the clinician charge stated as a number before intake. Three tiers are published.
- Wrong for
- A reader budgeting a year at $129. The founding rate ends without a published date.
How KERNX Health compares
| Seller | Who it suits | Go |
|---|---|---|
| NextMeds | A reader who wants one charge covering medication and care, and who treats a rate running under a countdown timer as an intro rather than a standing price. | See NextMeds → |
 AVARA Rx | A reader who wants the consult inside the price, and who plans against the standing rate rather than a code that can be withdrawn. | See AVARA Rx → |
| EverSlim | A reader who wants one monthly charge covering the medication, the visit and the postage, without a prepay term attached to reach the rate. | See EverSlim → |
More GLP-1 telehealth sellers reviews: LibertyMaximusNovaPallas HealthPlushCarePreventiveMD
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Is the consultation fee charged before approval?
- No. KERNX states that it applies only when treatment is approved. A declined applicant pays nothing.
- How long does the founding rate last?
- No end date is published. The page states that the standard rates of $249 and $299 apply once founding membership closes.
- Does the price rise with the dose?
- No. Both rates are stated as flat at every dose. A dose change may still require a visit, and that visit is priced separately.
- Is KERNX Health expensive compared with other GLP-1 telehealth sellers?
- KERNX Health publishes a starting figure of $129/mo. Across the 32 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $139, which puts KERNX Health below the median, toward the cheaper end. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.